Norway· NO-ID_0F38B9F8-7B62-4F6E-BC10-316A907AAC74
Imbruvica
A ibrutinib product containing ibrutinib, registered in Norway by Janssen-Cilag International N.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ibrutinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EL01 (ibrutinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Ibrutinib · ATC L01EL01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ibrutinib costs, country by country.
Normalised to the WHO defined daily dose (0.42 g), the median price runs from $4.92 in France to $193.73 in Switzerland — a ×39 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ibrutinib · price per daily dose (0.42 g)
USD · FX 28 Sept 2026
- CH Switzerland$193.73
- FR France$4.92
The record
At a glance
FEST (Norway)- Active substance
- Ibrutinib
- Manufacturer
- Janssen-Cilag International N.V.
- Country
- Norway (NO)
- ATC code
- L01EL01
- ATC class
- Ibrutinib
- Defined daily dose
- 0.42 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_0F38B9F8-7B62-4F6E-BC10-316A907AAC74
- no_varenummer14105128NOK 94010.6
- gtin7323281005209
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
370 interactions on record for ibrutinib.
Graded by severity as the source publishes them — 189 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ibrutinib · interactions on record
370 records
- 189 severe
- 177 moderate
- 4 minor
Most severe, free to view
- AprepitantA04AD12severe
- LinseedA06AC05severe
- LonafarnibA16AX20severe
- DicoumarolB01AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ibrutinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIMBRUVICAJanssen-Cilag International N.V., Beerse
- SwitzerlandImbruvica
- SpainIMBRUVICA 560 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- FinlandImbruvicaJanssen-Cilag International NV
- FranceIMBRUVICA 560 mg, comprimé pelliculéJANSSEN CILAG INTERNATIONAL NV
- IrelandIMBRUVICA 560 mg film-coated tabletsJanssen-Cilag International NV
- IcelandIMBRUVICAJanssen-Cilag International NV*
- NetherlandsIMBRUVICA 560 mg filmomhulde tablettenJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Imbruvica
- Liechtenstein · Imbruvica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7eed1e5-dcb6-4bfb-9661-e58f39df0554 GET /v1/drugs/d7eed1e5-dcb6-4bfb-9661-e58f39df0554?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Ibrutinib",
"merkevare_id": "ID_0F38B9F8-7B62-4F6E-BC10-316A907AAC74",
"name_form_strength": "Imbruvica tab 560 mg",
"prescription_group": "C"
}See everything about ibrutinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.